Global drug demand is growing rapidly, fueled by a growing population worldwide, rising chronic diseases, and healthcare expenses. The biotech market is playing a crucial role and catering to the diverse global demand supported by rapid technological innovation and increasing R&D.
Against this backdrop, it could be wise to invest in fundamentally strong biotech stocks Illumina, Inc. (ILMN), Amgen Inc. (AMGN), and Entrada Therapeutics, Inc. (TRDA) with significant growth potential.
